Lifetech Scientific (01302): IBS Coronary Stent Has Obtained EU CE MDR Certification

Zhitong Finance APP news, Lifetech Scientific (01302) announced that on October 29, 2026, the IBS absorbable drug-eluting coronary stent system (IBS coronary stent or the Product) independently developed by Yuanxin Technology (Shenzhen) Co., Ltd. (Yuanxin), a subsidiary of the Group, has obtained EU CE MDR certification, making it the world's first iron-based coronary stent system to receive sales authorization.